Circadian Rhythms in Patients With IBD or Celiac Disease Upon Diagnosis and Medical Follow-up
NCT03662646 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2023-02-22
Summary
patients 6-25 years old upon diagnostic evaluation will be recruited . study population will comprise of two groups: newly diagnosed IBD patients/ Celiac disease and healthy controls.
upon enrollment, subjects will fill out sleeping habits questioners, demographic data, medical history.
blood samples will be drawn for CRP and clock gene expression in systemic WBC. intestinal biopsies will be snap frozen for clock gene extraction and amplification only for patients with IBD.
Conditions
- Inflammatory Bowel Diseases
- Circadian Dysregulation
Interventions
- OTHER
-
no intervention performed- observational only
no intervention performed- observational only
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 6 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-31
- Primary Completion
- 2022-07-31
- Completion
- 2022-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Inflammatory Bowel Disease Related Joint Manifestations
NCT05693311 ·Status: UNKNOWN
-
Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients.
NCT05835973 ·Status: RECRUITING ·Phase: NA
-
Telomere Repair Gene Mutation in Inflammatory Bowel Disease
NCT00353639 ·Status: COMPLETED
-
GI Symptoms and Sleep Disturbances in Patients With Quiescent Crohns Disease
NCT02245594 ·Status: UNKNOWN
-
Chronotherapy in Inflammatory Bowel Disease
NCT04304950 ·Status: COMPLETED ·Phase: PHASE4
-
Stress in Crohn's Disease
NCT04809194 ·Status: COMPLETED
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Cytokines and Genes in Therapeutic Response in Crohn's Disease
NCT03266471 ·Status: COMPLETED
-
Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease
NCT03266484 ·Status: COMPLETED ·Phase: NA
-
Impact of Morning Light Therapy in IBD
NCT07207200 ·Status: RECRUITING ·Phase: NA
-
A Gratitude Intervention in Improving Well-being and Coping in People Living With Inflammatory Bowel Disease
NCT03059186 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Multimodal Lifestyle Intervention on Chronic Fatigue in Patients With Inflammatory Bowel Disease
NCT05374967 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease
NCT07078994 ·Status: RECRUITING ·Phase: PHASE2
-
Assessing Cardiovascular Dysfunction Pre- & Post-treatment in Inflammatory Bowel Diseases
NCT03615287 ·Status: UNKNOWN
-
Hormonal Influences on Inflammatory Bowel Diseases
NCT05610527 ·Status: COMPLETED
-
Disease Course in an IBD Cohort in the Era of Biological Treatment
NCT01468090 ·Status: COMPLETED
-
Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases
NCT02878395 ·Status: UNKNOWN
-
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
NCT00586599 ·Status: COMPLETED ·Phase: NA
-
Autoimmune Protocol Diet and Inflammatory Bowel Disease
NCT03512327 ·Status: COMPLETED ·Phase: NA
-
Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases
NCT03841045 ·Status: UNKNOWN
-
Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease
NCT03836612 ·Status: COMPLETED
-
Curcumin Supplementation as an Add on Treatment for Patients With Inflammatory Bowel Diseases Treated With Vedolizumab
NCT03500653 ·Status: UNKNOWN ·Phase: NA
-
The Mind-Body IBD Study: Understanding the Mind-body Connection in IBD
NCT06116331 ·Status: RECRUITING
-
Advanced Therapy Registry of IBD Patients
NCT04998084 ·Status: UNKNOWN
-
Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease
NCT00101946 ·Status: COMPLETED ·Phase: PHASE2